THE SITUS JUDI MBL77 DIARIES

Not all patients with CLL need therapy. Regardless of all current improvements, the iwCLL nevertheless endorses watchful observation for sufferers with asymptomatic disorder.86 This suggestion is based on at the very least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (